Top Stock Movers Sept 22, 2026: LHSW, RAIN, GRML

LHSW — Lianhe Sowell International Group Ltd (+103.8%)

Shares of Lianhe Sowell International Group doubled on Tuesday, closing at $0.88 — up 103.8% — on extraordinary volume of 250,993,726 shares, roughly 12× its 20-day average of 20,768,601. For a company with a market cap of just $22.5M, that kind of turnover signals an intense, single-day news-driven surge rather than any broad accumulation trend.

Why it moved: On September 22, Yahoo Finance reported that Lianhe Sowell signed a Strategic Cooperation Agreement with a subsidiary of Chery Group Holding Company to advance intelligent equipment in China's automotive aftermarket. Chery is one of China's largest automakers, so even a subsidiary-level deal drew immediate speculative interest in this micro-cap name.

From a technical standpoint, the setup was not strong before the news. StockSetups rated LHSW with a conviction score of 24/100 and a grade of D, while its RSI sat at just 40 and the moving-average stack was bearish. The stock was also sitting 98.3% below its 52-week high — a reminder of how far it had fallen before today's gap. The day's gap was +192.2% on an intraday basis, meaning the stock opened dramatically above Monday's close before settling at $0.88. With a technical rank of just 8 and an RS rating of 1, this is purely a news-driven, momentum event in a deeply beaten-down stock. LHSW also recently completed an IPO process (F-1/A, F-1MEF, and 424B4 filings in late August/early September), so the share structure may still be evolving.

One notable flag: the largest disclosed stake stands at 97.7%, implying a very concentrated ownership structure with minimal float — meaning even modest buying pressure can produce explosive price swings. That same thinness cuts both ways. LHSW appeared in our premarket recap earlier today, and today's close marks a sharp continuation of those early gains.

RAIN — Rain Enhancement Technologies Holdco, Inc. (+60.4%)

Rain Enhancement Technologies closed at $1.06, up 60.4%, on volume of 30,568,702 shares — approximately 16.8× its 20-day average of 1,821,725. The stock's market cap stands at $21.1M, firmly in micro-cap territory. Volume this far above normal in a name this small typically indicates a short-term momentum burst rather than a sustained institutional move.

Why it moved: No news headline or SEC filing is on file for today. With no identifiable catalyst, this move appears to be technically and momentum-driven — possibly fueled by the stock's prior insider-buying history and its low-float characteristics attracting speculative interest. The CEO, Randy Seidl, has been a consistent buyer, accumulating shares across five separate Form 4 transactions between May and August 2026, purchasing a total of more than 262,000 shares. That pattern of insider buying can attract attention from retail momentum traders even when no new catalyst is announced.

Technically, RAIN printed a morning star candlestick — a three-candle reversal pattern that signals potential exhaustion of a downtrend and a shift in buying/selling balance — which may have attracted technically-oriented traders. RSI registered 59, reflecting solid momentum without yet crossing into overbought territory. The ADX of 17 is low, indicating the trend is not yet strongly directional. The stock remains 87.0% below its 52-week high, and the MA stack is still bearish, underscoring how far it has to recover. The conviction score is 24/100, grade D.

Because no confirmed news catalyst exists, traders should treat this move with particular caution. Momentum runs in no-news micro-caps with thin floats can reverse just as quickly as they start.

GRML — Greenland Mines Ltd (+49.5%)

Greenland Mines closed at $14.08, up 49.5%, on volume of 87,689,175 shares — about 5.4× its 20-day average of 16,288,653. With a market cap of $1.5B, GRML is the largest name in today's mover list by a wide margin, and it enters the session with StockSetups' highest possible conviction score of 100/100 (grade A+).

Why it moved: According to reporting from EBC Financial Group and multiple other outlets on September 21–22, GRML surged on the back of a U.S.-Denmark-Greenland security agreement that spotlighted Greenland's critical mineral resources. Headlines referenced the deal as a driver of explosive moves across Greenland-linked stocks, with GRML specifically cited for its role in highlighting critical minerals following the agreement. As Yahoo Finance noted on September 21, Greenland Mines itself put out commentary emphasizing its positioning in the critical minerals space in the wake of the diplomatic news.

This is a multi-day continuation move — our September 21 close recap and September 21 premarket recap both featured GRML prominently as the security deal first broke. Today's +49.5% adds to what headlines described as a +230–245% cumulative surge over the prior two sessions.

The technical picture is the strongest of today's movers. RSI reached 77 — solidly overbought — and the gap was +45.4%. GRML's technical rank of 69 and conviction of 100/100 reflect confirmed momentum. One headwind to watch: a September 4 8-K flagged potential dilution, and an August 27 follow-on offering (424B5) is a bearish structural note, as companies sometimes use price spikes to raise capital. The CFO, Jeff LeBlanc, did buy 14,000 shares ($136K) in late August. Smart-money score is 39/100.

FLNA — Filana Therapeutics, Inc. (+37.9%)

Filana Therapeutics closed at $1.02, up 37.9%, on volume of 88,844,153 shares — roughly 18.9× its 20-day average of 4,695,761. At a market cap of $35.5M, FLNA is a micro-cap biotech where single regulatory decisions can move the stock violently in either direction.

Why it moved: The catalyst is clear and significant. On September 22, Yahoo Finance reported that Filana Therapeutics announced the FDA had lifted the clinical hold on Simufilam, its lead drug candidate, enabling the company to proceed with a Phase 2a study in TSC-related epilepsy (TSC stands for tuberous sclerosis complex, a rare genetic disorder). A clinical-hold lift — meaning the FDA had previously paused the trial and has now cleared it to continue — is a binary positive event for clinical-stage biotechs, and markets responded accordingly.

The technical picture shows a gap open of +32.9%, with RSI at 66 and ADX at 35 — the latter indicating a strengthening trend. StockSetups' conviction score came in at 43/100, with the stock sitting 51.2% below its 52-week high, suggesting significant damage in the chart before today's news. There is an important risk flag: a September 18 8-K disclosed delisting risk, meaning FLNA may not meet the minimum standards for its exchange listing. That overhang does not disappear with a single positive FDA event, and investors should weigh it carefully. Reddit's r/all-stocks gave FLNA a rank of #155 with 3 mentions — a modest social signal rather than a full-blown retail frenzy.

Biotech stocks with delisting concerns and clinical-stage pipelines carry compounded risk. Today's FDA news is genuinely positive, but it is one step in a long clinical and regulatory road.

CWD — CaliberCos Inc. (+37.5%)

CaliberCos closed at $0.71, up 37.5%, on 28,884,498 shares — approximately 17.6× its 20-day average of 1,641,453. The company operates in Financials and carries a market cap of just $5.3M, making it the smallest name on today's list and among the most speculative.

Why it moved: No news headline is on file for today, making the catalyst unclear. This move appears to be momentum- and technically-driven. The stock printed an inverted hammer candlestick — a single-candle pattern that can signal a potential bullish reversal after a downtrend, particularly when accompanied by a spike in volume. With RSI at 71 (approaching overbought) and a gap of +13.1%, buying pressure clearly accelerated early in the session. The ADX of 11 is very low, however, suggesting the directional trend has not yet established itself.

Two recent bearish SEC filings are important context: a September 15 8-K flagged dilution and an August 26 8-K disclosed delisting risk — the same pair of structural headwinds seen in FLNA. With a conviction score of 40/100, grade D, and the stock sitting 88.5% below its 52-week high, the chart reflects a deeply distressed name. The MA stack is mixed. A no-news, high-volume spike in a sub-$1 stock with delisting risk and a recent dilution filing demands maximum caution. These kinds of moves can be driven by a small number of market participants and can reverse without warning.

The bottom line

Tuesday's biggest gainers were a mix of news catalysts — a China automotive partnership, a geopolitical security deal, and an FDA clinical-hold lift — alongside two names where no clear catalyst was identified and momentum appeared to do the heavy lifting. That mix is typical of the most volatile end of the US equity universe.

A few honest risk reminders before you act on anything above:

• Chasing extended gainers is high-risk. Stocks that double or surge 50% in a single session frequently give back a significant portion of those gains in the days that follow — sometimes the very next morning.
• Low float and micro-cap names amplify both moves and reversals. A thin float (the portion of shares actively available to trade) means a small amount of buying or selling can swing the price dramatically. That's exciting on the way up and painful on the way down.
• Short squeezes and momentum runs eventually run out of fuel. When new buyers stop arriving, price can collapse quickly.
• Structural risks matter. Multiple names today carry active delisting warnings or dilution filings. Those are not minor footnotes — they directly affect shareholder value.
• This article is educational only and is not financial advice or a recommendation to buy or sell any security. Do your own research and manage your risk accordingly.

StockSetups scans the full ~12,300-stock US universe after every market close, detecting chart patterns confirmed by candlesticks, computing conviction and short-squeeze scores, and sorting setups into actionable lanes — so you can see tomorrow's potential movers before the open. Check back for the premarket recap on September 23.